OncoZenge News and Activities

OncoZenge is a company listed under the stock ticker ONCOZ (SE).

View the org chart displaying its 9 main executives

Most searched biographies at OncoZenge

• Stian Kildal, Chief Executive Officer
• Niclas Holmgren, Board Member
• Daniel Ehrenstråhle, Chairman of the Board

Popular executive movements at OncoZenge

• Linda Nord has joined the company as Head of Regulatory Affairs  (posted on June 4 2026).
• Marie-Louise Fjällskog has joined the company as Chief Medical Officer  (posted on February 3 2026).

Create your alert
to follow the executive moves at OncoZenge.

OncoZenge has 2,428 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by OncoZenge

Social media about OncoZenge

• OncoZenge on Wikipedia, Google News & Yahoo Finance
• OncoZenge on LinkedIn, X (Twitter) & YouTube